Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Explore how index level and market sentiment work together to create actionable trading signals, with simple steps to apply in your analysis.
28,655 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Federal investigators have seized over $61 million in USDT linked to romance scam operations, tracing the funds throu...
Equities drift lower as oil prices jump, lifting energy shares and weighing on risk appetite. The S&P 500 retreats wh...
In 2026, the equal-weight S&P 500 index has posted impressive breadth-driven gains, outpacing the cap-weight S&P 500 ...
Investors woke up to a modest rally in Intel as executives highlighted strong demand and expansion plans. This articl...
The Vanguard Total World Bond ETF now trades with a 4.1% yield, wrapping investment-grade bonds from more than 50 cou...
A director sold 3,000 BlackLine shares in an open-market move. Here’s how to interpret that action, what it says abou...
June inflation fell as energy and shelter costs cooled, pushing traders to delay expectations of a near-term Fed rate...
SpaceX isn’t your typical public stock, but the question remains: should spacex stock below the IPO price be a buying...
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Midweek market wobble hides bigger truths. This Wednesday reads guide helps you spot breadth, compare active choices,...
GitLab delivered solid revenue growth but offered modest profitability guidance, triggering a sharp stock move. This ...